Stankevicius E, Lopez-Valverde V, Rivera L, Hughes A D, Mulvany M J, Simonsen Ulf
Department of Pharmacology, Faculty of Health Sciences, University of Aarhus, Aarhus C, Denmark.
Br J Pharmacol. 2006 Nov;149(5):560-72. doi: 10.1038/sj.bjp.0706886. Epub 2006 Sep 11.
The present study investigated whether calcium-activated K+ channels are involved in acetylcholine-evoked nitric oxide (NO) release and relaxation.
Simultaneous measurements of NO concentration and relaxation were performed in rat superior mesenteric artery and endothelial cell membrane potential and intracellular calcium ([Ca2+]i) were measured.
A combination of apamin plus charybotoxin, which are, respectively, blockers of small-conductance and of intermediate- and large-conductance Ca2+ -activated K channels abolished acetylcholine (10 microM)-evoked hyperpolarization of endothelial cell membrane potential. Acetylcholine-evoked NO release was reduced by 68% in high K+ (80 mM) and by 85% in the presence of apamin plus charybdotoxin. In noradrenaline-contracted arteries, asymmetric dimethylarginine (ADMA), an inhibitor of NO synthase inhibited acetylcholine-evoked NO release and relaxation. However, only further addition of oxyhaemoglobin or apamin plus charybdotoxin eliminated the residual acetylcholine-evoked NO release and relaxation. Removal of extracellular calcium or an inhibitor of calcium influx channels, SKF96365, abolished acetylcholine-evoked increase in NO concentration and [Ca2+]i. Cyclopiazonic acid (CPA, 30 microM), an inhibitor of sarcoplasmic Ca2+ -ATPase, caused a sustained NO release in the presence, but only a transient increase in the absence, of extracellular calcium. Incubation with apamin and charybdotoxin did not change acetylcholine or CPA-induced increases in [Ca2+]i, but inhibited the sustained NO release induced by CPA.
Acetylcholine increases endothelial cell [Ca2+]i by release of stored calcium and calcium influx resulting in activation of apamin and charybdotoxin-sensitive K channels, hyperpolarization and release of NO in the rat superior mesenteric artery.
本研究调查钙激活钾通道是否参与乙酰胆碱诱发的一氧化氮(NO)释放及舒张反应。
在大鼠肠系膜上动脉中同时测量NO浓度和舒张反应,并测量内皮细胞膜电位及细胞内钙浓度([Ca2+]i)。
蜂毒明肽与蝎毒素(分别为小电导和中大电导钙激活钾通道的阻滞剂)联用,可消除乙酰胆碱(10微摩尔)诱发的内皮细胞膜电位超极化。在高钾(80毫摩尔)环境下,乙酰胆碱诱发的NO释放减少68%,在蜂毒明肽与蝎毒素存在时减少85%。在去甲肾上腺素收缩的动脉中,NO合酶抑制剂不对称二甲基精氨酸(ADMA)可抑制乙酰胆碱诱发的NO释放及舒张反应。然而,只有进一步添加氧合血红蛋白或蜂毒明肽与蝎毒素,才能消除残余的乙酰胆碱诱发的NO释放及舒张反应。去除细胞外钙或使用钙内流通道抑制剂SKF96365,可消除乙酰胆碱诱发的NO浓度及[Ca2+]i升高。肌浆网Ca2+ -ATP酶抑制剂环匹阿尼酸(CPA,30微摩尔)在有细胞外钙存在时可引起持续的NO释放,但在无细胞外钙时仅引起短暂升高。用蜂毒明肽和蝎毒素孵育不会改变乙酰胆碱或CPA诱导的[Ca2+]i升高,但会抑制CPA诱导的持续NO释放。
在大鼠肠系膜上动脉中,乙酰胆碱通过释放储存钙及钙内流增加内皮细胞[Ca2+]i,并导致蜂毒明肽和蝎毒素敏感的钾通道激活、超极化及NO释放。